Abstract
Asia Pacific Drug Delivery Devices Investment Opportunities, Analysis and
Forecasts to 2012
Summary
This report is an essential source for in-depth information and data relating
to Asia Pacific drug delivery devices market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the drug delivery devices in
Asia Pacific.
Scope
* The report provides drug delivery devices information broken down into
detailed categories in the Asia Pacific.
* Total revenues, products sold
and end users.
* Market shares of all the key competitors.
* Key
pipeline products that are set to shape the market, broken down by sector.
* Information on the top medical equipment companies in the sector in the
country covering business description, strategic analysis, and financial
information.
* Healthcare structure, regulatory environment, approval
process, pricing trends and reimbursement.
* Product and brand updates,
strategy changes, R&D projects, corporate expansions and contractions and
regulatory changes.
* Key mergers and acquisitions, partnerships, private
equity investments and IPOs.
* Customer, hospitals and physicians data.
Reasons to buy
* Gain a strong understanding of the drug delivery devices market in Asia
Pacific.
* Evaluate and compare the attractiveness of the market in the
region.
* Identify growth segments and opportunities in each industry
sector within the region.
* Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the region.
* Analyze the competitiveness of the
market in the region and identify hotspots.
* Develop strategies based on
the latest product, brand, expansion and research and development news in the
region.
* Do deals with an understanding of how competitors are financed,
and the mergers and partnerships that have shaped the market in the
region.
* Identify and analyze the strengths and weaknesses of the
industry incumbents in the region.
Table of Contents
1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of
the Markets Covered in the Report 13
3.1 Drug delivery devices 13
3.2
Inhalation Systems 13
3.2.1 Metered Dose Inhaler 13
3.2.2 Dry powder
inhaler 13
3.3 Infusion Systems 13
3.3.1 Infusion pumps 13
3.3.2
Syringe pumps 14
3.3.3 Disposable Infusion sets 14
3.4 Needle-free
Injections 14
4 Drug Delivery Devices in Asia Pacific 15
4.1 Drug
Delivery Devices Cross Country Comparison (2000-2012) 15
4.2 Drug Delivery
Devices, Asia Pacific, Overall Revenues ($ mn), 2000-2012 16
4.3 Drug
Delivery Devices, Asia Pacific, Company Share (2006-2007) 20
5 Drug
Delivery Devices In Japan 21
5.1 Drug Delivery Devices, Japan, Overall
Revenues ($ mn), 2000-2012 21
5.2 Drug Delivery Devices, Japan, Category
Volume (Units), 2000-2012 24
5.3 Drug Delivery Devices, Japan,
Distribution Share (2006-2007) 27
5.3.1 Infusion Systems Distribution
Share (2006-2007) 27
5.3.2 Inhalation Systems Distribution Share
(2006-2007) 27
5.3.3 Needle Free Injections Distribution Share (2006-2007)
28
5.4 Drug Delivery Devices, Japan, Company Share (2006-2007) 29
5.4.1 Drug Delivery Devices, Japan, Company Share (2006-2007) 29
5.4.2
Infusion Systems, Japan, Company Share (2006-2007) 30
5.4.3 Inhalation
Systems, Japan, Company Share (2006-2007) 31
6 Drug Delivery Devices In
China 32
6.1 Drug Delivery Devices, China, Overall Revenues ($ mn),
2000-2012 32
6.2 Drug Delivery Devices, China, Category Volume (Units),
2000-2012 35
6.3 Drug Delivery Devices, China, Distribution Share
(2006-2007) 38
6.3.1 Infusion Systems Distribution Share (2006-2007)
38
6.3.2 Inhalation Systems Distribution Share (2006-2007) 38
6.4 Drug
Delivery Devices, China, Company Share (2006-2007) 39
6.4.1 Drug Delivery
Devices, China, Company Share (2006-2007) 39
6.4.2 Infusion Systems,
China, Company Share (2006-2007) 40
6.4.3 Inhalation Systems, China,
Company Share (2006-2007) 41
7 Drug Delivery Devices In Australia 42
7.1 Drug Delivery Devices, Australia, Overall Revenues ($ mn), 2000-2012
42
7.2 Drug Delivery Devices, Australia, Category Volume (Units),
2000-2012 45
7.3 Drug Delivery Devices, Australia, Distribution Share
(2006-2007) 48
7.3.1 Infusion Systems Distribution Share (2006-2007)
48
7.3.2 Inhalation Systems Distribution Share (2006-2007) 48
7.4 Drug
Delivery Devices, Australia, Company Share (2006-2007) 49
7.4.1 Drug
Delivery Devices, Australia, Company Share (2006-2007) 49
7.4.2 Infusion
Systems, Australia, Company Share (2006-2007) 50
7.4.3 Inhalation Systems,
Australia, Company Share (2006-2007) 51
8 Drug Delivery Devices In India
52
8.1 Drug Delivery Devices, India, Overall Revenues ($ mn), 2000-2012
52
8.2 Drug Delivery Devices, India, Category Volume (Units), 2000-2012
55
8.3 Drug Delivery Devices, India, Distribution Share (2006-2007) 58
8.3.1 Infusion Systems Distribution Share (2006-2007) 58
8.3.2 Inhalation
Systems Distribution Share (2006-2007) 58
8.4 Drug Delivery Devices,
India, Company Share (2006-2007) 59
8.4.1 Drug Delivery Devices, India,
Company Share (2006-2007) 59
8.4.2 Infusion Systems, India, Company Share
(2006-2007) 60
8.4.3 Inhalation Systems, India, Company Share (2006-2007)
62
9 AstraZeneca PLC Company Profile 63
9.1 Company Overview 63
10
GlaxoSmithKline plc Company Profile 64
10.1 Company Overview 64
11
Cardinal Health, Inc. Company Profile 65
11.1 Company Overview 65
11.2
Value Chain Analysis 65
11.2.1 Manufacturing 66
11.2.1.1 In House
Manufacturing 66
11.2.1.2 Outsourcing 66
11.2.2 Product Development
66
11.2.2.1 Regulatory Approvals 66
11.2.2.2 Research and Development
66
11.2.3 Sales and Marketing 67
11.2.3.1 Partnerships and Alliances
67
11.2.3.2 Licensing Agreements 67
12 3M Company Company Profile
68
12.1 Company Overview 68
12.2 Value Chain Analysis 69
12.2.1
Manufacturing 69
12.2.1.1 In House Manufacturing 69
12.2.2 Product
Development 69
12.2.2.1 Regulatory Approvals 69
12.2.2.2 Clinical
Trials 69
12.2.2.3 Research and Development 70
12.2.3 Sales and
Marketing 70
12.2.3.1 Partnerships and Alliances 70
12.2.3.2 Licensing
Agreements 70
12.2.3.3 E-distribution 70
13 Baxter International Inc.
Company Profile 71
13.1 Company Overview 71
13.2 Value Chain Analysis
72
13.2.1 Manufacturing 72
13.2.1.1 In House Manufacturing 72
13.2.2 Product Development 72
13.2.2.1 Regulatory Approvals 72
13.2.2.2 Clinical Trials 73
13.2.2.3 Research and Development 73
13.2.3 Sales and Marketing 73
13.2.3.1 Partnerships and Alliances 73
13.2.3.2 Licensing Agreements 73
13.2.3.3 E-distribution 74
13.3
Baxter International Inc. Pipeline Products 74
13.3.1 Baxter International
Inc. Pipeline Products By Equipment Type 74
13.3.2 Baxter International
Inc. Pipeline Products By Development Stage 74
13.3.3 Baxter International
Inc. Pipeline Products By Therapy Area 74
13.3.4 Baxter International Inc.
Pipeline Products By Clinical Trials 75
13.3.5 Baxter International Inc.
Pipeline Products By News Summary 75
14 Novartis Medical Nutrition Company
Profile 76
14.1 Company Overview 76
15 Boehringer Ingelheim GmbH
Company Profile 77
15.1 Company Overview 77
15.2 Value Chain Analysis
78
15.2.1 Manufacturing 78
15.2.1.1 In House Manufacturing 78
15.2.1.2 Outsourcing 78
15.2.2 Product Development 79
15.2.2.1
Regulatory Approvals 79
15.2.2.2 Clinical Trials 79
15.2.2.3 Research
and Development 79
15.2.3 Sales and Marketing 79
15.2.3.1 Licensing
Agreements 79
15.2.3.2 Partnerships and Alliances 79
16 B. Braun
Melsungen AG Company Profile 80
16.1 Company Overview 80
16.2 Value
Chain Analysis 80
16.2.1 Manufacturing 81
16.2.1.1 In House
Manufacturing 81
16.2.1.2 Outsourcing 81
16.2.2 Product Development
81
16.2.2.1 Regulatory Approvals 81
16.2.2.2 Clinical Trials 81
16.2.2.3 Research and Development 82
16.2.3 Sales and Marketing 82
16.2.3.1 Partnerships and Alliances 82
16.2.3.2 Licensing Agreements
82
17 AKAS Medical Company Profile 84
17.1 Company Overview 84
18
Daiken Medical Co., Ltd. Company Profile 85
18.1 Company Overview 85
19 Emco Meditek Private Limited Company Profile 86
19.1 Company Overview
86
20 Plenum Technologies Private Limited Company Profile 86
20.1
Company Overview 86
21 pSivida Limited Company Profile 87
21.1 Company
Overview 87
21.2 pSivida Limited Pipeline Products 87
21.2.1 pSivida
Limited Pipeline Products By Equipment Type 87
21.2.2 pSivida Limited
Pipeline Products By Development Stage 87
21.2.3 pSivida Limited Pipeline
Products By Therapy Area 88
21.2.4 pSivida Limited Pipeline Products By
Clinical Trials 88
21.2.5 pSivida Limited Pipeline Products By News
Summary 88
22 Unomedical Pty Ltd Company Profile 89
22.1 Company
Overview 89
23 Financial Deals Landscape 90
23.1 Acquisition 90
24
Recent Developments 92
24.1 Product News 92
24.1.1 Dec 12, 2008:
pSivida New Clinical Trial For Drug Delivery Device In AMD 92
24.1.2 Dec
03, 2008: pSivida' s BrachySil Pancreatic Cancer Treatment Featured On The BBC
92
24.1.3 Jul 07, 2008: BrachySil Phase IIb Pancreatic Cancer Trials
Commence 92
24.1.4 Jan 28, 2008: BioSphere Medical Receives Market
Clearance To Sell Embosphere Microspheres In The People' s Republic Of China
93
25 APPENDIX 94
25.1 Global Markets Direct Research Methodology
94
25.2 Coverage 95
25.3 Secondary Research 95
25.4 Primary
Research 96
25.5 Models 96
25.6 Forecasts 97
25.7 Expert Panels
97
25.8 Currency Conversion 98
25.9 Contact Us 99
25.10 Disclaimer
99
1.1 List of Tables
Table 1: Drug Delivery Devices, Asia
Pacific, Cross Country Comparison, Revenues ($ mn), (2000-2012) 14
Table
2: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn),
2000-2012 15
Table 3: Drug Delivery Devices, Asia Pacific, Overall
Revenues ($ mn), 2000-2012 16
Table 4: Drug Delivery Devices, Asia
Pacific, Overall Revenues ($ mn), Historic, 2000-2007 17
Table 5:
Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), Forecast,
2007-2012 18
Table 6: Drug Delivery Devices, Asia Pacific, Company
Share by Revenue ($ mn), 2006-2007 19
Table 7: Drug Delivery Devices,
Japan, Overall Revenues ($ mn), 2000-2012 20
Table 8: Drug Delivery
Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007 21
Table 9:
Drug Delivery Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
22
Table 10: Drug Delivery Devices, Japan, Category Volume (Units),
2000-2012 23
Table 11: Drug Delivery Devices, Japan, Category Volume
(Units), Historic, 2000-2007 24
Table 12: Drug Delivery Devices,
Japan, Category Volume (Units), Forecast, 2007-2012 25
Table 13:
Infusion Systems, Japan, Distribution Share by Revenue ($mn), 2006-2007 26
Table 14: Inhalation Systems, Japan, Distribution Share by Revenue ($mn),
2006-2007 26
Table 15: Needle Free Injections, Japan, Distribution
Share by Revenue ($mn), 2006-2007 27
Table 16: Drug Delivery Devices,
Japan, Company Share by Revenue ($ mn), 2006-2007 28
Table 17:
Infusion Systems, Japan, Company Share by Revenue ($ mn), 2006-2007 29
Table 18: Inhalation Systems, Japan, Company Share by Revenue ($ mn),
2006-2007 30
Table 19: Drug Delivery Devices, China, Overall Revenues
($ mn), 2000-2012 31
Table 20: Drug Delivery Devices, China, Overall
Revenues ($ mn), Historic, 2000-2007 32
Table 21: Drug Delivery
Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012 33
Table 22:
Drug Delivery Devices, China, Category Volume (Units), 2000-2012 34
Table 23: Drug Delivery Devices, China, Category Volume (Units),
Historic, 2000-2007 35
Table 24: Drug Delivery Devices, China,
Category Volume (Units), Forecast, 2007-2012 36
Table 25: Infusion
Systems, China, Distribution Share by Revenue ($mn), 2006-2007 37
Table
26: Inhalation Systems, China, Distribution Share by Revenue ($mn),
2006-2007 37
Table 27: Drug Delivery Devices, China, Company Share by
Revenue ($ mn), 2006-2007 38
Table 28: Infusion Systems, China,
Company Share by Revenue ($ mn), 2006-2007 39
Table 29: Inhalation
Systems, China, Company Share by Revenue ($ mn), 2006-2007 40
Table 30:
Drug Delivery Devices, Australia, Overall Revenues ($ mn), 2000-2012 41
Table 31: Drug Delivery Devices, Australia, Overall Revenues ($ mn),
Historic, 2000-2007 42
Table 32: Drug Delivery Devices, Australia,
Overall Revenues ($ mn), Forecast, 2007-2012 43
Table 33: Drug
Delivery Devices, Australia, Category Volume (Units), 2000-2012 44
Table
34: Drug Delivery Devices, Australia, Category Volume (Units), Historic,
2000-2007 45
Table 35: Drug Delivery Devices, Australia, Category
Volume (Units), Forecast, 2007-2012 46
Table 36: Infusion Systems,
Australia, Distribution Share by Revenue ($mn), 2006-2007 47
Table 37:
Inhalation Systems, Australia, Distribution Share by Revenue ($mn), 2006-2007
47
Table 38: Drug Delivery Devices, Australia, Company Share by
Revenue ($ mn), 2006-2007 48
Table 39: Infusion Systems, Australia,
Company Share by Revenue ($ mn), 2006-2007 49
Table 40: Inhalation
Systems, Australia, Company Share by Revenue ($ mn), 2006-2007 50
Table
41: Drug Delivery Devices, India, Overall Revenues ($ mn), 2000-2012
51
Table 42: Drug Delivery Devices, India, Overall Revenues ($ mn),
Historic, 2000-2007 52
Table 43: Drug Delivery Devices, India,
Overall Revenues ($ mn), Forecast, 2007-2012 53
Table 44: Drug
Delivery Devices, India, Category Volume (Units), 2000-2012 54
Table 45:
Drug Delivery Devices, India, Category Volume (Units), Historic, 2000-2007
55
Table 46: Drug Delivery Devices, India, Category Volume (Units),
Forecast, 2007-2012 56
Table 47: Infusion Systems, India,
Distribution Share by Revenue ($mn), 2006-2007 57
Table 48:
Inhalation Systems, India, Distribution Share by Revenue ($mn), 2006-2007
57
Table 49: Drug Delivery Devices, India, Company Share by Revenue
($ mn), 2006-2007 58
Table 50: Infusion Systems, India, Company Share
by Revenue ($ mn), 2006-2007 60
Table 51: Inhalation Systems, India,
Company Share by Revenue ($ mn), 2006-2007 61
Table 52: Baxter
International Inc. Pipeline Products by Equipment Type 73
Table 53:
Baxter International Inc. Pipeline Products By Development Stage 73
Table
54: Baxter International Inc. Pipeline Products By Therapy Area 73
Table 55: Baxter International Inc. Pipeline Products By Clinical Trials
74
Table 56: Baxter International Inc. Pipeline Products By News
Summaries 74
Table 57: pSivida Limited Pipeline Products by Equipment
Type 86
Table 58: pSivida Limited Pipeline Products By Development
Stage 86
Table 59: pSivida Limited Pipeline Products By Therapy Area
87
Table 60: pSivida Limited Pipeline Products By Clinical Trials
87
Table 61: pSivida Limited Pipeline Products By News Summaries
87
Table 62: Smiths Group Acquires Zhejiang Zheda Medical Instrument
89
Table 63: Clinical Cell Culture Merges With Visiomed Group 90
Table 64: Currency Conversion from USD to Local Currency at 2007 Constant
Rate 97
1.2 List of Figures
Figure 1: Drug Delivery Devices,
Asia Pacific, Cross Country Comparison, Revenues ($ mn), (2000-2012) 15
Figure 2: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn),
2000-2012 16
Figure 3: Drug Delivery Devices, Asia Pacific, Portfolio
Analysis, 2000-2012 17
Figure 4: Drug Delivery Devices, Asia Pacific,
Overall Revenues ($ mn), Historic, 2000-2007 18
Figure 5: Drug
Delivery Devices, Asia Pacific, Overall Revenues ($ mn), Forecast, 2007-2012
19
Figure 6: Drug Delivery Devices, Asia Pacific, Company Share (%),
2007 20
Figure 7: Drug Delivery Devices, Japan, Overall Revenues ($
mn), 2000-2012 21
Figure 8: Drug Delivery Devices, Japan, Overall
Revenues ($ mn), Historic, 2000-2007 22
Figure 9: Drug Delivery
Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012 23
Figure 10:
Drug Delivery Devices, Japan, Category Volume (Units), 2000-2012 24
Figure 11: Drug Delivery Devices, Japan, Category Volume (Units),
Historic, 2000-2007 25
Figure 12: Drug Delivery Devices, Japan,
Category Volume (Units), Forecast, 2007-2012 26
Figure 13: Drug
Delivery Devices, Japan, Company Share (%), 2007 29
Figure 14:
Infusion Systems, Japan, Company Share (%), 2007 30
Figure 15:
Inhalation Systems, Japan, Company Share (%), 2007 31
Figure 16: Drug
Delivery Devices, China, Overall Revenues ($ mn), 2000-2012 32
Figure 17:
Drug Delivery Devices, China, Overall Revenues ($ mn), Historic, 2000-2007
33
Figure 18: Drug Delivery Devices, China, Overall Revenues ($ mn),
Forecast, 2007-2012 34
Figure 19: Drug Delivery Devices, China,
Category Volume (Units), 2000-2012 35
Figure 20: Drug Delivery
Devices, China, Category Volume (Units), Historic, 2000-2007 36
Figure 21:
Drug Delivery Devices, China, Category Volume (Units), Forecast,
2007-2012 37
Figure 22: Drug Delivery Devices, China, Company Share
(%), 2007 39
Figure 23: Infusion Systems, China, Company Share (%),
2007 40
Figure 24: Inhalation Systems, China, Company Share (%), 2007
41
Figure 25: Drug Delivery Devices, Australia, Overall Revenues ($
mn), 2000-2012 42
Figure 26: Drug Delivery Devices, Australia,
Overall Revenues ($ mn), Historic, 2000-2007 43
Figure 27: Drug
Delivery Devices, Australia, Overall Revenues ($ mn), Forecast, 2007-2012
44
Figure 28: Drug Delivery Devices, Australia, Category Volume
(Units), 2000-2012 45
Figure 29: Drug Delivery Devices, Australia,
Category Volume (Units), Historic, 2000-2007 46
Figure 30: Drug
Delivery Devices, Australia, Category Volume (Units), Forecast, 2007-2012
47
Figure 31: Drug Delivery Devices, Australia, Company Share (%),
2007 49
Figure 32: Infusion Systems, Australia, Company Share (%),
2007 50
Figure 33: Inhalation Systems, Australia, Company Share (%),
2007 51
Figure 34: Drug Delivery Devices, India, Overall Revenues ($
mn), 2000-2012 52
Figure 35: Drug Delivery Devices, India, Overall
Revenues ($ mn), Historic, 2000-2007 53
Figure 36: Drug Delivery
Devices, India, Overall Revenues ($ mn), Forecast, 2007-2012 54
Figure 37:
Drug Delivery Devices, India, Category Volume (Units), 2000-2012 55
Figure 38: Drug Delivery Devices, India, Category Volume (Units),
Historic, 2000-2007 56
Figure 39: Drug Delivery Devices, India,
Category Volume (Units), Forecast, 2007-2012 57
Figure 40: Drug
Delivery Devices, India, Company Share (%), 2007 59
Figure 41:
Infusion Systems, India, Company Share (%), 2007 60
Figure 42:
Inhalation Systems, India, Company Share (%), 2007 62
Figure 43:
Cardinal Health, Inc. Value Chain Analysis 65
Figure 44: 3M
Healthcare Value Chain Analysis 69
Figure 45: Baxter International
Inc. Value Chain Analysis 72
Figure 46: Boehringer Ingelheim GmbH
Value Chain Analysis 78
Figure 47: B. Braun Melsungen AG Value Chain
Analysis 80
Figure 48: Global Markets Direct Methodology 94
|
有關報告
|
